Advanced Search

 

Study ID Status Title Patient Level Data
AK1A4002 Completed A Multicenter, Double-Blind, Placebo-Controlled Comparison of the Effects on Sexual Functioning of Wellbutrin (Bupropion HCl) Sustained Release and Sertraline in Outpatients with Moderate to Severe Recurrent Major Depression
AK1A4003 Completed A Multicenter, Double-Blind, Randomized Pilot Study Comparing the Safety and Efficacy of Wellbutrin (Bupropion HCl) Sustained Release and Paroxetine in the Treatment of Elderly Outpatients with Moderate to Severe Recurrent Major Depression
AK1A4004 Completed A Multicenter Placebo-Controlled Study of WELLBUTRIN (Bupropion Hydrochloride) Sustained Release (SR) for the Prevention of Relapse/Recurrence in Subjects Whose Depression Responded to Treatment With WELLBUTRIN SR
AK1A4005 Completed A Multicenter Evaluation of Wellbutrin (Bupropion Hydrochloride) Sustained Release, Habitrol (Nicotine Transdermal System), and Combination Wellbutrin Sustained Release/Habitrol Treatment Versus Placebo as Aids to Smoking Cessation. Study Listed on ClinicalStudyDataRequest.com
AK1A4006 Completed A Multicenter, Double-Blind, Placebo-Controlled Comparison of the Safety and Efficacy and Effects on Sexual Functioning of Wellbutrin (Bupropion HCl) Sustained Release (SR) and Fluoxetine in Outpatients with Moderate to Severe Recurrent Major Depression
AK1A4007 Completed A Multicenter, Double-Blind, Placebo-Controlled Comparison of the Safety and Efficacy and Effects on Sexual Functioning of Wellbutrin (Bupropion HCl) Sustained Release (SR) and Fluoxetine in Outpatients with Moderate to Severe Recurrent Major Depression
AK1A4008 Completed A Multi-Centre, Parallel, Randomised, Open-label, 1-Year Evaluation of the Effects of Zyban [bupropion hydrochloride sustained release tablets – BUP(SR)] and Nicorette DS (nicotine polacrilex double strength) as Aids to Smoking Cessation in Adult Chronic Cigarette Smokers
AK1A4010 Completed A Parallel, Randomized, Double-Blind, Placebo-Controlled, 1-Year Pilot Study of the Effects of ZYBAN† (Bupropion Hydrochloride Sustained Release Tablets) as an Aid to Smoking Cessation in Adult Cigarette Smokers Who are Not Motivated to Quit Smoking
AK1A4011 Completed An open-label study to evaluate Zyban as an aid to smoking cessation treatment in adult smokers receiving Medicaid.
AK1A4013 Completed A multicenter evaluation of the effects of Zyban (bupropion hydrochloride sustained release tablets) versus placebo in a population of smokers with COPD: treatment phase.ZYBAN is a registered trademark of the GlaxoSmithKline group of companies. Study Listed on ClinicalStudyDataRequest.com
AK1A4013_1 Completed A multicenter evaluation of the effects of Zyban™ (bupropion hydrochloride sustained release tablets) versus placebo in a population of smokers with COPD: Follow-up phase. Study Listed on ClinicalStudyDataRequest.com
AK1A403 Completed A multicenter dose response evaluation of Wellbutrin† (Bupropion hydrochloride) sustained release versus placebo as an aid to smoking cessation. Study Listed on ClinicalStudyDataRequest.com
AK1A406 Completed A multicenter comparison of bupropion hydrochloride sustained-release versus placebo for the prevention of relapse in patients who quit smoking while taking bupropion sustained-release Study Listed on ClinicalStudyDataRequest.com
AK1B1001 Completed The pharmacokinetics and tolerability of Wellbutrin SR after oral administration of a single 150 mg dose in patients with liver cirrhosis and healthy volunteers.
AK1BIOVAIL2526 Completed A pilot, one-period, three-way, cross-over, steady state, open-label, multiple-dose, fasting, comparative bioavailability study of two formulations of bupropion hydrochloride extended release tablets ( 300mg four times daily) versus WELLBUTRIN™ tablets ( 100mg twice daily andthree times daily) in normal healthy non-smoking male volunteers.
AK1BIOVAIL2543 Completed A two-way, crossover, steady state, multiple-dose, open-label, fasting, comparative bioavailability study of bupropion HCl 300mg extended release tablets (1 X 300mg four times daily) versus WELLBUTRIN 100mg tablets (three times daily) in normal healthy non-smoking male and female subjects
AK1BIOVAIL2544 Completed A two-way, crossover, steady state, multiple-dose, open-label, fasting, comparative bioavailability study of bupropion HCl 300mg extended release tablets (300mg four times daily) versus Wellbutrin 100mg tablets (three times daily) in normal healthy non-smoking male and female subjects
AK1BIOVAIL2548 Completed A two-way, crossover, open-label, single dose, food-effect, comparative bioavailability study of bupropion HCI extended release 300mg tablets in normal healthy non-smoking male and female subjects
AK1BIOVAIL2571 Completed A two-way, crossover, open-label, single-dose, fasting, dosage strength equivalency study of two strengths (150mg and 300mg) of bupropion HCI extended release tablets given once daily in normal healthy non-smoking male and female subjects
AK1BIOVAIL2572 Completed A two-way, steady state, crossover, open-label, multiple-dose, fasting, comparative bioavailability study of bupropion HCl 30mg extended-release tablets versus Zyban 150mg tablets in normal healthy non-smoking male and female subjects.
AK1BIOVAIL2573 Completed A four-way, crossover, open-label, single-dose, fasting and food effect, comparative bioavailability study of bupropion HCl extended-release 150mg tablets and Zyban 150mg tablets in normal healthy non-smoking male and female subjects
AK1BIOVAIL2594 Completed A four-period, four-treatment, crossover, open-label, single-dose, fasting, in-vitro/in-vivo correlation pharmacokinetic study of three formulations of bupropion HCl extended release 150 mg tablets (fast release, target release and slow release formulations) and bupropion HCl 100 mg oral solution in normal healthy non-smoking male subjects
AKIA401 Completed A single-center evaluation of Wellbutrin (bupropion hydrochloride) versus placebo as an aid to smoking cessation in heavy smokers (study 401)
ALB110247 Completed Randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and efficacy of Retapamulin ointment, 1% applied twice daily for 3 or 5 days to the anterior nares of healthy adult subjects nasally colonized with Staphylococcus aureus Study Listed on ClinicalStudyDataRequest.com
ALKF1001 Completed Report of a Biocomparability Study of Alkeran (melphalan) in Patients with Multiple Myeloma, Ovarian Cancer, Breast Cancer or other solid tumors for which Alkeran has activity.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.